ArticleCancer science2021

dUTPase inhibition confers susceptibility to a thymidylate synthase inhibitor in DNA-repair-defective human cancer cells.

Tatsushi Yokogawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.